Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond

SIMPLE SUMMARY: The treatment of patients with relapsed/refractory multiple myeloma has advanced considerably in recent years, irrespective of whether they are younger or older patients. Treating patients with relapsed/refractory multiple myeloma and renal impairment is far more complicated than tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozic, Boris, Rutner, Jens, Zheng, Chang, Ruckser, Reinhard, Selimi, Flonza, Racz, Krysztina, Köcher, Martin, Tatzreiter, Georg, Sebesta, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533858/
https://www.ncbi.nlm.nih.gov/pubmed/34680184
http://dx.doi.org/10.3390/cancers13205036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533858/
https://www.ncbi.nlm.nih.gov/pubmed/34680184
http://dx.doi.org/10.3390/cancers13205036

Ejemplares similares